/SWGHF
SWGHF Stock - Sawai Group Holdings Co., Ltd.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$11.52+0.00%
+$0.00 (+0.00%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.48
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $12.67
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SWGHF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$11.40 – $11.64
TARGET (TP)$13.25
STOP LOSS$10.60
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.01
52W High$13.40
52W Low$11.52
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $189.02B | $176.86B | $200.34B | $193.82B | $187.22B |
| Gross Profit | $56.35B | $54.32B | $62.63B | $66.65B | $72.43B |
| Gross Margin | 29.8% | 30.7% | 31.3% | 34.4% | 38.7% |
| Operating Income | $20.81B | $18.62B | $16.39B | $-4,451,000,000 | $18.89B |
| Net Income | $22.94B | $13.70B | $12.67B | $-28,269,000,000 | $12.34B |
| Net Margin | 12.1% | 7.7% | 6.3% | -14.6% | 6.6% |
| EPS | $185.01 | $312.67 | $96.42 | $-645.54 | $281.81 |
Company Overview
Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research, development, manufacturing, and marketing of generic pharmaceutical products primarily in Japan and the United States. The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, granules, capsules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms in the therapeutic areas of cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, chemotherapeutic agents, etc., as well as vitamin preparations. It sells its generic drugs to distributors, wholesalers, and retailers in Japan and the United States. The company was founded in 1929 and is headquartered in Osaka, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SWGHFBeat Rate
39%
Last 18 quarters
Avg Surprise
+20.1%
EPS vs Estimate
Beats / Misses
7/11
Last 12 quarters
Latest EPS
$0.00
Q4 2025
EPS Surprise History
Q1 24
+279.8%
$0.82vs$0.22
Q2 24
-86.2%
$0.01vs$0.10
Q3 24
+250.9%
$2.20vs$0.63
Q4 24
-37.8%
$0.20vs$0.32
Q1 25
+39.3%
$0.35vs$0.25
Q2 25
-303.8%
$-0.15vs$0.07
Q3 25
+23.6%
$0.29vs$0.24
Q4 25
-99.8%
$0.00vs$0.20
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 12, 2026 | — | — | — | — |
Q1 2026 | Feb 13, 2026 | — | — | — | — |
Q4 2025 | Nov 14, 2025 | $0.20 | $0.00 | -99.8% | ✗ MISS |
Q3 2025 | Aug 12, 2025 | $0.24 | $0.29 | +23.6% | ✓ BEAT |
Q2 2025 | May 14, 2025 | $0.07 | $-0.15 | -303.8% | ✗ MISS |
Q1 2025 | Feb 12, 2025 | $0.25 | $0.35 | +39.3% | ✓ BEAT |
Q4 2024 | Nov 11, 2024 | $0.32 | $0.20 | -37.8% | ✗ MISS |
Q3 2024 | Aug 9, 2024 | $0.63 | $2.20 | +250.9% | ✓ BEAT |
Q2 2024 | May 13, 2024 | $0.10 | $0.01 | -86.2% | ✗ MISS |
Q1 2024 | Feb 14, 2024 | $0.22 | $0.82 | +279.8% | ✓ BEAT |
Q3 2023 | Sep 30, 2023 | $0.17 | $0.75 | +330.8% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $0.22 | $0.55 | +152.6% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | $0.38 | $0.31 | -16.6% | ✗ MISS |
Q1 2023 | Feb 12, 2023 | $1.86 | $0.73 | -61.0% | ✗ MISS |
Q4 2022 | Nov 8, 2022 | $0.88 | $0.48 | -45.4% | ✗ MISS |
Q3 2022 | Aug 10, 2022 | $0.87 | $0.63 | -27.7% | ✗ MISS |
Q2 2022 | May 11, 2022 | $-7.62 | $-7.80 | -2.2% | ✗ MISS |
Q1 2022 | Feb 14, 2022 | $1.51 | $1.28 | -15.2% | ✗ MISS |
Q4 2021 | Nov 12, 2021 | $0.96 | $0.63 | -34.9% | ✗ MISS |
Q3 2021 | Aug 5, 2021 | $1.14 | $1.31 | +14.9% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about SWGHF
What is SWGHF's current stock price?
Sawai Group Holdings Co., Ltd. (SWGHF) is currently trading at $11.52 per share. The stock has moved +0.00% today.
What is the analyst price target for SWGHF?
No analyst price targets are currently available for this stock.
What sector is Sawai Group Holdings Co., Ltd. in?
Sawai Group Holdings Co., Ltd. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is SWGHF's market cap?
Sawai Group Holdings Co., Ltd. has a market capitalization of $1.33 billion, making it a small-cap company.
Does SWGHF pay dividends?
No, Sawai Group Holdings Co., Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBIOGY
BioGaia AB (publ)
$10.35
Mkt Cap: $1.1B
CHIZF
China Traditional Chinese Medicine Holdings Co. Limited
$0.27
Mkt Cap: $1.4B
CMOPF
Cosmo Pharmaceuticals N.V.
$130.61
Mkt Cap: $2.1B
EVOTF
Evotec SE
$8.01
Mkt Cap: $1.4B
KSPHF
Kissei Pharmaceutical Co., Ltd.
$26.97
Mkt Cap: $1.1B
LJUIF
SSY Group Limited
$0.40
Mkt Cap: $1.2B
NPNKF
Nippon Shinyaku Co., Ltd.
$30.51
Mkt Cap: $2.1B
NPPNY
Nippon Shinyaku Co., Ltd.
$9.52
Mkt Cap: $2.6B
TCNNF
Trulieve Cannabis Corp.
$8.53
Mkt Cap: $1.6B
TWAPF
Towa Pharmaceutical Co., Ltd.
$16.83
Mkt Cap: $0.8B
Explore stocks similar to SWGHF for comparison